1-8 of 8
Kristin McGregor
Close
Sort by
Journal Articles

Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

Philip C. Amrein, Eyal C. Attar, Geoffrey G Fell, Traci M. Blonquist, Andrew M. Brunner, Gabriela S. Hobbs, Hanno R. Hock, Steven McAfee, Rupa Narayan, Jenna A. Moran, Meghan Bergeron, Julia E. Foster, Christina Bertoli, Kristin McGregor, Meghan Burke, Tanya T. Behnan, Tina T. Som, Aura Y. Ramos, Megan K. Vartanian, Jennifer Lombardi Story, Donna S. Neuberg, Amir T. Fathi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3309–3311.
https://doi.org/10.1182/blood-2022-160100
Published: 2022
Journal Articles

Phase I Study of Ixazomib Added to Chemotherapy in the Treatment of Acute Lymphoblastic Leukemia in Older Adults

Philip C. Amrein, MD, Karen K. Ballen, MD, Kristen E. Stevenson, MS, Traci M. Blonquist, MS, Andrew M. Brunner, Gabriela S. Hobbs, MD, Hanno R. Hock, MD PhD, Steven L. McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, NP, Julia E. Foster, NP, Christina Bertoli, NP, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, RN, Megan K. Vartanian, RN, Jennifer Lombardi Story, Christine Connolly, Timothy A. Graubert, MD, Donna S. Neuberg, ScD, Amir T. Fathi
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-139661
Published: 2020
Journal Articles

Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

Philip C. Amrein, MD, Eyal C. Attar, MD, Geoffrey Fell, Traci M. Blonquist, MS, Andrew M. Brunner, Gabriela S. Hobbs, MD, Hanno R. Hock, MD PhD, Steven L. McAfee, MD, Rupa Narayan, MD, Jenna A. Moran, NP, Meghan Bergeron, NP, Julia E. Foster, NP, Christina Bertoli, NP, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, RN, Megan K. Vartanian, RN, Jennifer Lombardi Story, Donna S. Neuberg, ScD, Amir T. Fathi
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-140584
Published: 2020
Journal Articles

Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

Monica Kasbekar, Valentina Nardi, MD, Paola Dal Cin, Andrew M. Brunner, MD, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, MD, Julia Foster, ANP, Molly Macrae, Steven L McAfee, MD, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, RN, Megan Vartanian, RN, Robb S Friedman, MD, Karim Benhadji, MD MSC, Gabriela S. Hobbs, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5371.
https://doi.org/10.1182/blood-2019-124100
Published: 2019
Journal Articles

Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Myeloid Leukemia in Older Adults

Philip C. Amrein, MD, Eyal C. Attar, MD, Traci M. Blonquist, MS, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Donna S Neuberg, ScD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4059.
https://doi.org/10.1182/blood-2018-99-117566
Published: 2018
Journal Articles

Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia

Andrew M. Brunner, MD, Traci M. Blonquist, MS, Daniel J. DeAngelo, MD, Malgorzata McMasters, MD, Eric S. Winer, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Hanno Hock, MD PhD, David P. Steensma, Jacqueline S. Garcia, Marlise R. Luskin, MD, Richard M. Stone, MD, Karen K. Ballen, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD, Steven L McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Kaitlyn Fishman, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Nicole Nelson, Emma Logan, Jennifer Lombardi Story, Christine Connolly, Donna S Neuberg, ScD, Yi-Bin Chen, MD, Timothy A. Graubert, MD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 766.
https://doi.org/10.1182/blood-2018-99-115145
Published: 2018
Journal Articles

Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

Philip C. Amrein, MD, Karen K. Ballen, MD, Traci M. Blonquist, MS, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven L McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Christine Connolly, Donna S Neuberg, ScD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2704.
https://doi.org/10.1182/blood-2018-99-117506
Published: 2018
Journal Articles

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

Amir T. Fathi, MD, Traci M. Blonquist, MS, Ashkan Emadi, MD PhD, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven L McAfee, MD, Robert P. Hasserjian, MD, Frederic I. Preffer, PhD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Kaitlyn Fishman, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Patricia Lesho, Vu H. Duong, MD, Mason Mann, Christopher Lescinskas, Christine Connolly, Donna S Neuberg, ScD, Karen K. Ballen, MD, Philip C. Amrein, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1431.
https://doi.org/10.1182/blood-2018-99-115031
Published: 2018